XML 24 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - ARS ($)
$ in Millions
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Operating activities:      
Net cash generated from / (used in) continuing operating activities before income tax paid $ 13,169 $ (2,710) $ 16,115
Income tax and minimum presumed income tax paid (492) (69) (746)
Net cash generated from / (used in) continuing operating activities 12,677 (2,779) 15,369
Net cash generated from discontinued operating activities 0 5,168 61,261
Net cash generated from operating activities 12,677 2,389 76,630
Investing activities:      
Contributions and issuance of capital in associates and joint ventures (125) (69) (6,654)
Acquisition and improvements of investment properties (6,134) (1,638) (9,058)
Contributions and issuance of capital in associates and joint ventures pending of susbscription (57) 0 0
Proceeds from sales of investment properties 25,977 29,737 443
Acquisitions and improvements of property, plant and equipment (335) (503) (621)
Proceeds from sales of property, plant and equipment 4 572 0
Acquisitions of intangible assets (65) (85) (107)
Dividends collected from associates and joint ventures 3,586 0 566
Proceeds from loans granted 453 15 4,434
(Payment)/ Proceeds of derivative financial instruments (77) (857) 12,195
Net increase of restricted assets, net 0 0 (515)
Acquisitions of investments in financial assets (22,871) (17,453) (37,955)
Proceeds from disposal of investments in financial assets 10,501 27,285 49,472
Interest received from financial assets 338 1,104 211
Loans granted to related parties 0 0 (407)
Net cash generated from / (used in) continuing investing activities 11,195 38,108 12,004
Net cash generated from discontinued investing activities 0 72,347 100,302
Net cash generated from investing activities 11,195 110,455 112,306
Financing activities:      
Borrowings and issuance of non-convertible notes 4,877 15,354 54,398
Payment of borrowings and non-convertible notes (10,926) (65,278) (66,463)
(Payment) / collections of short term loans, net (999) 8,409 6,197
Interests paid (8,186) (13,484) (13,296)
Repurchase of non-convertible notes (1,726) (8,412) (5,003)
Capital contributions from non-controlling interest in subsidiaries 40 43 0
Acquisition of non-controlling interest in subsidiaries 0 (123) (1,482)
Issuance of shares 0 6,776 0
Loans received from associates and joint ventures, net 24 0 0
Payment of borrowings to related parties (481) 0 0
Dividends paid to non-controlling interest in subsidiaries (181) (4,242) (546)
Warrants exercise 4 0 0
Proceeds from sales of own non-convertible notes 4,252 11,574 0
Payment of financial leases (36) (67) (116)
Repurchase of treasury shares (325) 0 0
Net cash used in continuing financing activities (13,663) (49,450) (26,311)
Net cash used in discontinued financing activities 0 (29,784) (173,386)
Net cash used in financing activities (13,663) (79,234) (199,697)
Net increase / (decrease) in cash and cash equivalents from continuing activities 10,209 (14,121) 1,062
Net increase / (decrease) in cash and cash equivalents from discontinued activities 0 47,731 (11,823)
Net increase / (decrease) in cash and cash equivalents 10,209 33,610 (10,761)
Cash and cash equivalents at beginning of the year 3,167 222,556 212,910
Cash and cash equivalents reclassified as held-for-sale 0 0 (1,109)
Inflation adjustment (399) (371) (500)
Deconsolidation of subsidiaries 0 (238,316) 0
Foreign exchange (loss)/gain on cash and unrealized fair value result for cash equivalents (201) (14,312) 22,016
Cash and cash equivalents at end of the year $ 12,776 $ 3,167 $ 222,556